LOTRIMIN AF DAILY PREVENTION deodorant powder spray can recalled over manufacturing violations
- Recall date
- October 1, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Bayer Healthcare Pharmaceuticals Inc. recalls LOTRIMIN AF (Tolnaftate 1%) DAILY PREVENTION deodorant powder spray NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare…
- Recall number
- D-0239-2022
- FDA classification
- Class II
- Brand / firm
- Bayer Healthcare Pharmaceuticals Inc.
- Sold / distributed
- Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.
Why it was recalled
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
LOTRIMIN AF (Tolnaftate 1%) DAILY PREVENTION deodorant powder spray NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland, UPC 0 41100 59036 7, NDC 11523-0010-1.
Get recall alerts
Free email alert whenever Bayer Healthcare Pharmaceuticals Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Bayer Healthcare Pharmaceuticals Inc.